• Macrophage Vimentin Variant Drives Cancer Metastasis

  2026-08-18

  A recent preprint identifies a macrophage-secreted, N-terminally truncated vimentin variant that promotes breast cancer cell migration through an IGF-1R–RSK–integrin αVβ6 axis. Its multi-model design links tumor-associated macrophage proteolysis and unconventional secretion to metastatic behavior, while patient-tissue associations suggest potential biomarker relevance that still requires independent validation.

• BEND Lipids Improve mRNA and CRISPR Delivery

  2026-08-18

  The reference study introduces branched endosomal disruptor (BEND) ionizable lipids that improve hepatic delivery of mRNA and CRISPR-Cas9 ribonucleoprotein complexes, as well as T-cell transfection, relative to non-branched lipid designs. Its mechanistic analyses link the performance gain to enhanced endosomal penetration and disruption, providing a structure-guided approach to overcoming a major bottleneck in nonviral nucleic-acid delivery.

• Comparative Gene Expression in the Mammalian Claustrum

  2026-08-17

  The reference study develops a cross-species framework for identifying conserved claustrum subdivisions by integrating gene expression, cytoarchitecture, and anatomical position. Its in situ hybridization analysis across rodents, shrews, and primates provides a foundation for interpreting claustrum organization beyond mouse models and for evaluating which structural features may be evolutionarily shared.

• 1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine Controls

  2026-08-16

  PP 3 is a practical negative control for PP 2 experiments, helping distinguish Src-dependent effects from vehicle, scaffold, and pathway-level artifacts. This workflow connects Src kinase signaling pathway research with ROS, calcium-channel, and vascular contraction assays while preserving clear experimental boundaries.

• Tacrine Hydrochloride Hydrate: Assay Logic

  2026-08-15

  Tacrine hydrochloride hydrate, also known as Tetrahydroaminacrine, is more than a cholinesterase inhibitor: it is a mechanistic probe for separating target engagement from downstream neurobiology. This guide combines cholinergic assay design with a metabolism-informed interpretation framework for Alzheimer's disease research.

• 3-Deazaadenosine: From SAH to m6A Assays

  2026-08-15

  3-Deazaadenosine is an S-adenosylhomocysteine hydrolase inhibitor that connects methylation metabolism with antiviral and epitranscriptomic assay design. This article explains how to use it as a mechanistic perturbation while avoiding overinterpretation of broad SAM-dependent methyltransferase inhibition.

• Phytol C5616 for Reliable Cell Assays

  2026-08-14

  Learn how Phytol (SKU C5616) can be integrated into cell viability, proliferation, and cytotoxicity workflows without confusing receptor biology, solvent effects, or assay interference. This scenario-based guide covers formulation, dose design, interpretation, and practical supplier selection.

• SERCA2 Dysfunction Links ROS to Pulmonary Remodeling

  2026-08-14

  The reference study identifies SERCA2 dysfunction as an upstream trigger of oxidative stress, inflammation, and pulmonary vascular remodeling through suppression of the PPARγ/PGC1α/Nrf2 pathway. Its genetic and pharmacological experiments connect calcium-handling failure with inflammatory recruitment and show that restoring pathway activity or reducing reactive oxygen species can lessen remodeling-related phenotypes.

• Mc-Val-Cit-PABC-PNP: ADC Linker Guide

  2026-08-13

  Mc-Val-Cit-PABC-PNP is a cathepsin-cleavable ADC peptide linker intended for research workflows that evaluate lysosomal payload release during antibody-drug conjugate synthesis. It is supplied as a DMSO-soluble solid for scientific research only and is not suitable for water- or ethanol-based preparation, diagnostic use, or therapeutic administration.

• A-1331852: Precision BCL-XL Inhibitor Workflows

  2026-08-13

  A-1331852 is a selective BCL-XL inhibitor for dissecting apoptotic dependence, chemotherapy-induced senescence, and combination response. This workflow-focused guide explains how to prepare, dose, validate, and troubleshoot the compound in cell-based cancer research.

• Rocilinostat (ACY-1215) Workflow for HDAC6 Studies

  2026-08-12

  Rocilinostat (ACY-1215) enables selective HDAC6 interrogation in multiple myeloma viability, apoptosis, and proteasome-inhibitor combination assays. This workflow also shows how acetylated α-tubulin measurements can support carefully bounded, hypothesis-generating studies of primary cilia and neural progenitor biology.

• Protease Inhibitor Cocktail for Reliable Protein Workflows

  2026-08-12

  Protect labile proteins across cell lysis, Western blotting, co-immunoprecipitation, and kinase workflows with broad-spectrum inhibition plus separate EDTA-based metalloprotease control. This practical guide translates a nasopharyngeal carcinoma DHODH study into reproducible sample-preparation choices, including when to remove EDTA before metal-affinity or two-dimensional electrophoresis.

• Ferrostatin-1 (Fer-1): Reliable Assay Design

  2026-08-11

  A scenario-driven guide to using Ferrostatin-1 (Fer-1), SKU A4371, to distinguish ferroptosis from nonspecific cytotoxicity and improve assay interpretation. It covers controls, solvent compatibility, concentration planning, cross-model limitations, and practical product-selection criteria.

• Temafloxacin: Assay Design Across Bacterial Models

  2026-08-10

  Temafloxacin is a fluoroquinolone broad-spectrum antibacterial agent whose assay value depends on pathogen, compartment, and endpoint selection. This guide translates comparative MIC evidence into practical extracellular, intracellular, respiratory, and in vivo research decisions.

• Recombinant Human Growth Hormone: Assay Workflows

  2026-08-09

  Build reproducible chondrocyte proliferation, differentiation, and IGF-1 pathway assays with a defined somatotropin reagent. This workflow translates the IGFBP2–THBS1 findings into practical controls, dose-finding steps, and troubleshooting decisions for bone and pituitary research.

458 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page